CARCINOMAS
Clinical trials for CARCINOMAS explained in plain language.
Never miss a new study
Get alerted when new CARCINOMAS trials appear
Sign up with your email to follow new studies for CARCINOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine aims to stop lung cancer from coming back after surgery
Disease control TerminatedThis study is testing a new personalized vaccine treatment for people who have had surgery for non-small cell lung cancer. The goal is to see if the vaccine, given with an immune-boosting drug, can train the body's immune system to recognize and attack any remaining cancer cells …
Matched conditions: CARCINOMAS
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New hope for rare kidney cancer: dual immunotherapy trial seeks better control
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs, nivolumab and relatlimab, can help control advanced renal medullary carcinoma (RMC), a rare and aggressive type of kidney cancer. The trial will enroll about 30 adults whose cancer has spread or cannot be rem…
Matched conditions: CARCINOMAS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
New hope for tough cervical cancer: experimental drug trial
Disease control OngoingThis study is testing an experimental immunotherapy drug called AK104 for women with a rare, aggressive form of cervical cancer that has returned or spread after prior chemotherapy. The main goal is to see if the drug can keep the cancer from growing for at least 6 months. Resear…
Matched conditions: CARCINOMAS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC